It doesnt have to be a Big Pharma - just a small or medium will...

It doesnt have to be a Big Pharma - just a small or medium will do.
Of the 35 odd patents licensed to Lyramid there is plenty of scope for a successful utilisation.
Not limited to the singular offerings of previous participants in Biotech, largely unsuccessful and unpatented with a lot of dodgy rhetoric from both them and the Blogger with its knickers in a twist.
Who knows how long it will take, but at least they are doing some work on advancing MK.
600 peer reviewed clinical papers to back up the MK.
Lyramid only has a licence to access them.
Im sure if there is any dodgy business that might threaten the entire process a licence termination would be in order.